Pediatr. praxi. 2021;22(2):121-124 | DOI: 10.36290/ped.2021.022

Leptospirosis as a rare cause of acute kidney injury in fourteen-year-old girl

MUDr. Patrik Konopásek1, MUDr. Ingeborg Vokálová2, MUDr. Ivana Divišová2, doc. MUDr. Jakub Zieg, Ph.D.1
1 Pediatrická klinika 2. LF UK a FN v Motole, Praha
2 Praktický lékař pro děti a dorost, Alergologie-imunologie pro děti a dospělé, Kralupy nad Vltavou

Acute kidney injury is a severe condition which increases both mortality and morbidity in children. There is a long term risk of development of chronic kidney disease even if the patient is treated properly. We present a case of a patient who developed acute kidney injury during the course of a febrile infection of unkown origin. The etiology was subsequently clarified after patient´s discharge from the hospital.

Keywords: acute kidney infury, febrile infection, leptospirosis.

Published: April 29, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Konopásek P, Vokálová I, Divišová I, Zieg J. Leptospirosis as a rare cause of acute kidney injury in fourteen-year-old girl. Pediatr. praxi. 2021;22(2):121-124. doi: 10.36290/ped.2021.022.
Download citation

References

  1. Ciccia E, Devarajan P. Pediatric acute kidney injury: prevalence, impact and management challenges. Int J Nephrol Renovasc Dis 2017; 10: 77-84. Go to original source... Go to PubMed...
  2. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Working Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2(1): 1-138.
  3. Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL. Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults. N Engl J Med 2017; 376: 11-20. Go to original source... Go to PubMed...
  4. Cho MH. Pediatric Acute Kidney Injury: Focusing on Diagnosis and Management. Child Kidney Dis 2020; 24(1): 19-26. Go to original source...
  5. Benisty K, Morgan C, Hessey E, et al. Kidney and blood pressure abnormalities 6 years after acute kidney injury in critically ill children: a prospective cohort study. Pedatri Res 2020; 88(2): 271-278. Go to original source... Go to PubMed...
  6. Lameire N, Van Biesen W, Vanholder R. Epidemiology of acute kidney injury in children worldwide, including developing countries. Pediatr Nephrol 2017; 32(8): 1301-1314. Go to original source... Go to PubMed...
  7. Zieg J, Skálová S. Dětská nefrologie do kapsy. Praha: Mladá fronta 2019: 399s.
  8. Adler B, De la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol 2010; 140(3-4): 287-296. Go to original source... Go to PubMed...
  9. Haake DAA, Paul N. LEVETT. Leptospirosis in Humans. Curr Top Microbiol Immunol 2015; 387: 65-97. Go to original source... Go to PubMed...
  10. European Centre for Disease Prevention and Control. Leptospirosis. Annual epidemiological report for 2015. Stockholm: ECDC; 2018.
  11. Segruo A C a Andrade L. Pathophysiology of Leptospirosis. Shock 2013; 39: 17-23. Go to original source... Go to PubMed...
  12. Da Silva Junior GB, Srisawat N, Galdino GS, et al. Acute kidney injury in leptospirosis: Overview and perspectives. Asian Pac J Trop Med 2018; 11(10). Go to original source...
  13. Day N. Leptospirosis: Epidemiology, microbiology, clinical manifestations, and diagnosis. In: uptodate.com [online]. [cit. 4-11-2020]. Dostupné z: https://www.uptodate.com/contents/leptospirosis-epidemiology-microbiology-clinical-manifestations-and-diagnosis?search=leptospirosis&source=search_result&selectedTitle=1~83&usage_type=default&display_rank=1#PATIENT_INFORMATION. Path: uptodate.com; Topics by Specialty; Infectious Diseases; Other bacterial infections;
  14. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003; 3(12): 757-771. Go to original source... Go to PubMed...
  15. Charan J, Saxena D, Mulla S, et al. Antibiotics for the treatment of leptospirosis: systematic review and meta-analysis of controlled trials. Int J Prev Med 2013; 4(5): 501-510.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.